Paper Details
- Home
- Paper Details
Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy Participants.
Author: BenhadjiKarim A, HeYaohua, HuntAllen, MutoToshiharu, SonnichsenDaryl, YamamiyaIkuo, YamashitaFumiaki
Original Abstract of the Article :
Futibatinib, a selective, irreversible fibroblast growth factor receptor 1-4 inhibitor, was recently approved for FGFR2 rearrangement-positive cholangiocarcinoma. This Phase I study evaluated the mass balance and metabolic profile of <sup>14</sup> C-futibatinib single oral 20-mg dose in healthy part...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1002/cpdd.1271
データ提供:米国国立医学図書館(NLM)
Decoding the Metabolic Journey of Futibatinib: A Phase 1 Study
Futibatinib, a promising new drug for treating certain types of cancer, has recently gained approval. This study delves into the pharmacokinetic profile of futibatinib, investigating how the drug is absorbed, distributed, metabolized, and excreted in healthy volunteers. It's like tracing the path of a traveler through the desert, understanding how the body processes and eliminates this potentially life-saving drug.
Futibatinib's Metabolic Odyssey: A Tale of Absorption and Elimination
The study revealed that futibatinib is rapidly absorbed after oral administration, reaching peak levels in the blood within an hour. The drug undergoes extensive metabolism, with the majority of the dose excreted in feces. The primary metabolic pathways involve O-desmethylation and glutathione conjugation, indicating the complexity of the body's drug processing machinery. It's like witnessing the transformation of a desert traveler, their journey marked by a series of chemical reactions that ultimately lead to elimination.
Optimizing Treatment: Navigating the Metabolic Landscape
Understanding the pharmacokinetic profile of futibatinib is crucial for optimizing treatment regimens and ensuring patient safety. This study provides valuable information for clinicians, allowing them to tailor dosages and monitor potential drug interactions effectively. It's like having a map of the desert, guiding healthcare professionals in their efforts to safely and effectively deliver this potentially life-saving drug.
Dr. Camel's Conclusion
This Phase 1 study offers a fascinating glimpse into the metabolic journey of futibatinib, a potentially life-saving drug for cancer patients. It's like exploring a vast desert, uncovering the secrets of the body's intricate drug processing system. By understanding the pharmacokinetic profile of this drug, we can work towards optimizing treatment regimens and ensuring that it reaches its intended target safely and effectively. It's a testament to the power of scientific inquiry, leading us toward a future where cancer can be treated with greater precision and effectiveness.
Date :
- Date Completed 2023-09-04
- Date Revised 2023-09-06
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.